Read all about us!
Nearly 3% of adults don’t know they have this serious medical condition With November being National Diabetes Month, it’s a good time to take stock of the toll this disease takes on our country. More than 34 million Americans have diabetes, and in 2017, the total estimated… Read More >
Use of COVID-19 testing and vaccination services at community pharmacies demonstrates they can play a bigger role in care delivery Community pharmacists are often overlooked for the vital roles they play in our health care system. But in the public health emergency of the… Read More >
Babson brings in top talent from the largest and most respected retail and health care services organizations in the country Austin, Texas — Babson Diagnostics, a science-first medical technology company, today announced the appointments of Kristie Stanton as vice president… Read More >
Austin, Texas - Babson Diagnostics, a transformative medical technology company improving customer access to diagnostic blood testing, today announced the closing of $31 million in an oversubscribed Series B funding round, led by Emerald Development Managers, with full… Read More >
Health and Wellness Drive Need for Faster, Cheaper, More Efficient Diagnostics We live in a just-in-time world. We only need to pick up our smartphones and within moments we order a car to drive us home. Or book a reservation at a hotel or restaurant. Or have dinner… Read More >
Austin, Texas — Babson Diagnostics, a transformative medical technology company improving customer access to diagnostic blood testing, was named one of Fierce Medtech’s elite “Fierce 15.” The honor recognizes Babson as one of the most promising private companies in the… Read More >
Austin, Texas - Babson Diagnostics, a transformative medical technology company, is improving the way the public receives diagnostic blood testing. According to the CDC, 70% of today’s medical decisions depend on laboratory test results, and over 14 billion laboratory tests… Read More >
Austin, Texas - Babson Diagnostics, a transformative medical technology company, has appointed David Stein, Ph.D., former head of global strategy and innovation at Siemens Healthineers, to chief executive officer. Eric Olson, Babson’s founder and former CEO, will assume the… Read More >
Austin, Texas - Babson Diagnostics, a transformative medical technology company, announced today it closed $13.7 million in cumulative Series A funding, led by Siemens Healthineers, Prism Ventures, Genesis Merchant Capital, and Lago Consulting Group. “With our strategic… Read More >
Austin, Texas - Babson Diagnostics, a transformative diagnostic blood testing company, announced today that its SARS-CoV-2 IgG antibody test, Babson Diagnostics aC19G1, has received emergency use authorization (EUA) from the Food and Drug Administration (FDA). Babson… Read More >